ClinicalTrials.gg
Status unknownNCT04749719remTDCSUpdated Jul 12, 2021

At Home Brain Stimulation Studies of Memory and Memory Awareness

An interventional study of remotely supervised transcranial direct current stimulation in Healthy, sponsored by Brooklyn College of the City University of New York. Status unknown at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-07-12.

Sponsored by Brooklyn College of the City University of New York · Not applicable, Interventional, and Basic science

How we know

The sponsor has not verified this record recently (last verified Apr 2021), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The main goal of this research is to determine the role of several brain regions in memory processes and cognitive functions. Participants will be remotely supervised via video chat while self-administering tDCS, a form of non-invasive brain stimulation. Before participating in the experiment, participants will be properly trained on use of the remote tDCS device and screened for eligibility. While using the tDCS device, participants will be engaging in tasks that assess different aspects of memory and executive functioning. By using remotely supervised tDCS while participants are completing these cognitive tasks, we will be able to make causal claims about the role of the targeted brain regions in different cognitive processes.

02

Conditions studied

  • Healthy

Keywords

  • transcranial direct current stimulation
  • memory
  • metacognition
  • brain
03

In context

Lead sponsor

Brooklyn College of the City University of New York is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • between the ages of 18-35
  • normal or corrected to normal vision
  • fluent in English and speaking English since age 5
  • right handed

Exclusion criteria

Exclusion Criteria:

  • chronic skin disease or medical skin condition
  • unhealed wound or open skin on the scalp, face, neck, or forehead
  • metal or electrode implants (e.g., cochlear implants, pacemakers, metal plates, rods, or screws in their head; for complete detail, see the screening form)
  • seizures or a family history of seizures, or are taking medications with a lowered seizure threshold
  • pregnant or lactating
  • any neurologic or psychiatric diseases
  • certain hair styles (dreadlocks, cornrows, etc) or hair coverings (e.g., wigs, hajibs, etc that will not be removed; note that a request can be made for an experimenter of a specific gender)
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    DLPFC stimulation

    F3-SO montage or OLE optimized with 2 mA stimulation for up to 30 min during memory and metamemory task.

    Device: remotely supervised transcranial direct current stimulation

  • Sham comparator
    Sham tDCS

    F3-SO montage or OLE optimized with sham stimulation for up to 30 min during memory and metamemory task.

    Device: remotely supervised transcranial direct current stimulation

Interventions

  • Deviceremotely supervised transcranial direct current stimulation

    Low levels of electrical current are applied across the scalp to induce small changes in brain activity. This is done using remote supervision.

06

What researchers measure

Primary outcomes

  1. Memory performance

    % Correct on the Memory Task

    Time frame: through study completion, an average of 4 weeks

Secondary outcomes

  1. Memory Confidence

    Average % Confidence on the Memory Task

    Time frame: through study completion, an average of 4 weeks

Other outcomes

  1. Metamemory Accuracy

    Calibration and resolution of confidence and accuracy.

    Time frame: through study completion, an average of 4 weeks

07

Study locations

1 of 1 sites recruiting
  • Brooklyn College
    Brooklyn, New York 11210, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2021 (actual). Primary completion is estimated for Aug 2022, 16 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 1, 2021
First posted
Feb 11, 2021
StartActual
Apr 15, 2021
Primary completionEst.
Aug 31, 2022
CompletionEst.
Aug 21, 2023
Last update
Jul 12, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 12, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04749719
Lead sponsor
Brooklyn College of the City University of New York
Responsible party
Elizabeth Chua (Associate Professor, Brooklyn College of the City University of New York) — Principal investigator
First posted
Feb 11, 2021
Start date
Apr 15, 2021
Primary completion
Aug 31, 2022 (estimated)
Completion
Aug 21, 2023 (estimated)
Last update
Jul 12, 2021

Study contacts

ELIZABETH CHUA, PHD
Contact
echua@brooklyn.cuny.edu
7189515000 ext. 6032
Casey Imperio, MS
Contact
cimperio@gradcenter.cuny.edu
6098464723

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion